Cutaneous drug hypersensitivity: developments and controversies.
Brockow K, Pfützner W.
Curr Opin Allergy Clin Immunol. 2019 Aug;19(4):308-318. doi: 10.1097/ACI.0000000000000548.
Cutaneous basophil hypersensitivity.
Dvorak HF.
J Allergy Clin Immunol. 1976 Jul;58(1 PT. 2):229-40. doi: 10.1016/0091-6749(76)90159-7.
Drug Hypersensitivity Reactions.
Wilkerson RG.
Immunol Allergy Clin North Am. 2023 Aug;43(3):473-489. doi: 10.1016/j.iac.2022.10.005.
Cutaneous Hypersensitivity-Like Reactions Associated With Breast Implants: A Review.
Labadie JG, Korta DZ, Barton N, Mesinkovska NA.
Dermatol Surg. 2018 Mar;44(3):323-329. doi: 10.1097/DSS.0000000000001448.
Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions.
Guvenir H, Arikoglu T, Vezir E, Misirlioglu ED.
Curr Pharm Des. 2019;25(36):3840-3854. doi: 10.2174/1381612825666191107162921.
Sulfonamide Hypersensitivity.
Chow TG, Khan DA.
Clin Rev Allergy Immunol. 2022 Jun;62(3):400-412. doi: 10.1007/s12016-021-08872-3. Epub 2021 Jul 1.
Predictors of immediate and delayed cutaneous hypersensitivity reactions to paclitaxel.
Trager MH, Kuo AM, Dusza SW, Park V, Geskin L, Guyer A, Abuhadra N, Gucalp A, Lacouture ME.
Arch Dermatol Res. 2024 Oct 9;316(9):665. doi: 10.1007/s00403-024-03402-5.
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.
Wei BM, Fox LP, Kaffenberger BH, Korman AM, Micheletti RG, Mostaghimi A, Noe MH, Rosenbach M, Shinkai K, Kwah JH, Phillips EJ, Bolognia JL, Damsky W, Nelson CA.
J Am Acad Dermatol. 2024 May;90(5):911-926. doi: 10.1016/j.jaad.2023.02.073. Epub 2023 Jul 28.
Cutaneous Manifestation of Drug Allergy and Hypersensitivity.
Zalewska-Janowska A, Spiewak R, Kowalski ML.
Immunol Allergy Clin North Am. 2017 Feb;37(1):165-181. doi: 10.1016/j.iac.2016.08.006.
Delayed Cutaneous Hypersensitivity Reactions to Antibiotics: Management with Desensitization.
McNulty CMG, Park MA.
Immunol Allergy Clin North Am. 2017 Nov;37(4):751-760. doi: 10.1016/j.iac.2017.07.002.
